Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2012Organic & Biomolecular Chemistry

Discovery of novel SERMs with a ferrocenyl entity based on the oxabicyclo2.2.1heptene scaffold and evaluation of their antiproliferative effects in breast cancer cells

View Full Paper
Ask AI
Bookmark
Share

Authors

YZYangfan ZhengZhejiang LabCWCaihua WangWuhan UniversityCLChanghao LiPennsylvania State University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zheng et al. (2012) studied this question.

synapsesocial.com/papers/6a8229367db08d7cfd3f10a3https://doi.org/10.1039/c2ob26226f
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Estrogen Receptor Binding Assay Method for Endocrine Disruptors Using Fluorescence Polarization2002 · 67 citations
  2. 2Advances in the Science of Estrogen Receptor Modulation2003 · 100 citations
  3. 3Structure-Based Design of Estrogen Receptor-β Selective Ligands2004 · 179 citations
  4. 4Molecular Determinants for the Tissue Specificity of SERMs2002 · 1,156 citations
  5. 5Identification and Structure–Activity Relationships of a Novel Series of Estrogen Receptor Ligands Based on 7-Thiabicyclo[2.2.1]hept-2-ene-7-oxide2012 · 42 citations